Ignite Creation Date:
2025-12-26 @ 10:20 PM
Ignite Modification Date:
2026-01-31 @ 9:58 PM
Study NCT ID:
NCT03815812
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2019-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With Hypercholesterolemia
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hypercholesterolemia | View |
Keywords: